The chronic debate over Lyme disease

  title={The chronic debate over Lyme disease},
  author={C. Ballantyne},
  journal={Nature Medicine},
nature medicine volume 14 | number 11 | november 2008 1135 It was 1994 and life could not have been better for Alita Lyons, an aspiring biochemist from Manhattan. As a child, Lyons had dreamed of working in science, and now, at age 27, she had landed her dream job: studying hepatitis C in a laboratory at the Weill Medical College of Cornell University in New York. All day and sometimes late into the night, Lyons sat at the lab bench pipetting chemicals into test tubes and running carefully… Expand
Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease
Post-treatment Lyme disease represents a narrow, defined, mechanistically-neutral subset of this larger, more heterogeneous group of patients, and is a useful definition in research settings as an initial subgroup of study. Expand
Scientific evidence and best patient care practices should guide the ethics of Lyme disease activism
Allegations of conflict of interest against the IDSA resemble those made against the National Institutes of Health, the Food and Drug Administration and the Centers for Disease Control and Prevention in 2000, which were found to be baseless. Expand
Treatment of Lyme borreliosis
If the infection is manifest, then treatment strategies should target not only the pathogen by using antibiotics but also the chronic inflammation by using anti-inflammatory drugs. Expand
Lyme Borreliosis in Canada: Biological Diversity and Diagnostic Complexity from an Entomological Perspective
Opportunities abound for entomologists to contribute to documenting the diversity of the players and their interactions in this devilishly complex disease. Expand
Living in Limbo
It is suggested that the social sequelae of PTLDS/CLD can be equally protracted as the physical effects of this illness. Expand
Bicarbonate therapy for infants.
Until metabolic acidosis is shown to have detrimental effects that can be corrected by bicarbonate infusion, such therapy should be seen as ‘‘basically useless therapy’’. Expand
Experiences of patients identifying with chronic Lyme disease in the healthcare system: a qualitative study
Four major themes emerged from participants’ descriptions of their experiences and perceptions: changes in health status and the social impact of chronic Lyme disease, doubts about recovery and the future, contrasting doctor-patient relationships, and the use of unconventional therapies to treat Chronic Lyme disease. Expand
Lyme borreliosis ( LB ) is a potentially debilitating illness that is typically vectored by ixodid ticks ( Acari : Ixodida : Ixodidae ) and caused by infection by the spirochete Borrelia burgdorferi
Lyme borreliosis (LB), also known as Lyme disease, is emerging as a serious tickborne illness across Canada. More than three decades of research on LB in North America and Europe have provided aExpand
5-Lipoxygenase–Deficient Mice Infected with Borrelia burgdorferi Develop Persistent Arthritis
It is demonstrated that products of the 5- LO metabolic pathway are not required for the development of disease in all models of arthritis and that caution should be used when targeting 5-LO as therapy for inflammatory diseases. Expand
An estimate of Lyme borreliosis incidence in Western Europe†
LB is a continually emerging disease and the most common zoonotic infection in Western Europe approaching endemic proportions in many European countries and Concordant and well-conducted surveillance and disease awareness should continue to be encouraged to monitor LB, as tick numbers and activity are increasing, leading to greater risks of infection. Expand